FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3039593619> ?p ?o ?g. }

• W3039593619 endingPage "jpet.120.265074" @default.
• W3039593619 startingPage "jpet.120.265074" @default.
• W3039593619 abstract "The sensation of pruritus, or itch, is associated with a variety of skin and medical disorders. Itch is transmitted through afferent C-fibers, and sodium channels play a key role in the transmission process. Local anesthetics, which block sodium channels, are used topically to treat itch but generally have a short duration of action and are not selective for afferent nerves underlying the itch sensation. Accordingly, there is a substantial unmet need for safe, efficacious, long-acting treatments for chronic pruritus, including nonhistaminergic itch. We investigated the dose-response, time to onset, and duration of action of ASN008 topical gel, which targets small afferent sodium channels, in a murine model of pruritus in which scratching behavior is induced by intradermal injection of chloroquine into the nape of the neck of C57BL/6 mice. Topical application of ASN008 gel resulted in a concentration-dependent reduction of scratching behavior. Onset of action was ≤1 hour, and duration of scratching inhibition was 15-24 hours. In a further study involving once-daily application for 5 days with chloroquine challenge on day 5, treatment with ASN008 gel again resulted in a concentration-dependent reduction of chloroquine-induced scratching, even when the gel was removed 3 hours after each daily application. In conclusion, topical ASN008 gel produces a dose-dependent reduction of scratching in a mouse model of pruritus, with a rapid onset and long duration of action, and may prove to be an effective, once-daily treatment of a variety of pruritic conditions in humans, including nonhistaminergic itch. SIGNIFICANCE STATEMENT: ASN008 gel produces a dose-dependent reduction of scratching in a mouse model of pruritus, with a rapid onset and long duration of action, and may prove to be an effective, once- or twice-daily treatment for a variety of pruritic conditions in humans. ASN008 gel has demonstrated good safety and tolerability in healthy volunteers and is currently under investigation in a phase 1b clinical study to evaluate safety, tolerability, pharmacokinetics, and preliminary antipruritic efficacy in atopic dermatitis patients (ClinicalTrials.gov ID: NCT03798561)." @default.
• W3039593619 created "2020-07-10" @default.
• W3039593619 creator A5019002401 @default.
• W3039593619 creator A5030214838 @default.
• W3039593619 creator A5032325957 @default.
• W3039593619 creator A5042389999 @default.
• W3039593619 creator A5042780256 @default.
• W3039593619 creator A5056163731 @default.
• W3039593619 creator A5077757684 @default.
• W3039593619 date "2020-07-02" @default.
• W3039593619 modified "2023-10-12" @default.
• W3039593619 title "Topical Application of ASN008, a Permanently-charged Sodium Channel Blocker, Shows Robust Efficacy, a Rapid Onset and Long Duration of Action in a Mouse Model of Pruritus" @default.
• W3039593619 cites W107290262 @default.
• W3039593619 cites W1974456266 @default.
• W3039593619 cites W1982147996 @default.
• W3039593619 cites W1997380538 @default.
• W3039593619 cites W2010822245 @default.
• W3039593619 cites W2011262436 @default.
• W3039593619 cites W2021997483 @default.
• W3039593619 cites W2040933141 @default.
• W3039593619 cites W2072653944 @default.
• W3039593619 cites W2072749656 @default.
• W3039593619 cites W2079474192 @default.
• W3039593619 cites W2085660659 @default.
• W3039593619 cites W2085720841 @default.
• W3039593619 cites W2087004322 @default.
• W3039593619 cites W2098416088 @default.
• W3039593619 cites W2105176852 @default.
• W3039593619 cites W2116411564 @default.
• W3039593619 cites W2128598867 @default.
• W3039593619 cites W2155717272 @default.
• W3039593619 cites W2157856809 @default.
• W3039593619 cites W2171205074 @default.
• W3039593619 cites W2271345340 @default.
• W3039593619 cites W2471162370 @default.
• W3039593619 cites W2588005135 @default.
• W3039593619 cites W2792910467 @default.
• W3039593619 cites W2898298752 @default.
• W3039593619 doi "https://doi.org/10.1124/jpet.120.265074" @default.
• W3039593619 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32616515" @default.
• W3039593619 hasPublicationYear "2020" @default.
• W3039593619 type Work @default.
• W3039593619 sameAs 3039593619 @default.
• W3039593619 citedByCount "1" @default.
• W3039593619 countsByYear W30395936192022 @default.
• W3039593619 crossrefType "journal-article" @default.
• W3039593619 hasAuthorship W3039593619A5019002401 @default.
• W3039593619 hasAuthorship W3039593619A5030214838 @default.
• W3039593619 hasAuthorship W3039593619A5032325957 @default.
• W3039593619 hasAuthorship W3039593619A5042389999 @default.
• W3039593619 hasAuthorship W3039593619A5042780256 @default.
• W3039593619 hasAuthorship W3039593619A5056163731 @default.
• W3039593619 hasAuthorship W3039593619A5077757684 @default.
• W3039593619 hasBestOaLocation W30395936191 @default.
• W3039593619 hasConcept C121332964 @default.
• W3039593619 hasConcept C16005928 @default.
• W3039593619 hasConcept C178790620 @default.
• W3039593619 hasConcept C185592680 @default.
• W3039593619 hasConcept C24890656 @default.
• W3039593619 hasConcept C2776414672 @default.
• W3039593619 hasConcept C2780196728 @default.
• W3039593619 hasConcept C42219234 @default.
• W3039593619 hasConcept C46821324 @default.
• W3039593619 hasConcept C50952357 @default.
• W3039593619 hasConcept C537181965 @default.
• W3039593619 hasConcept C71924100 @default.
• W3039593619 hasConcept C98274493 @default.
• W3039593619 hasConceptScore W3039593619C121332964 @default.
• W3039593619 hasConceptScore W3039593619C16005928 @default.
• W3039593619 hasConceptScore W3039593619C178790620 @default.
• W3039593619 hasConceptScore W3039593619C185592680 @default.
• W3039593619 hasConceptScore W3039593619C24890656 @default.
• W3039593619 hasConceptScore W3039593619C2776414672 @default.
• W3039593619 hasConceptScore W3039593619C2780196728 @default.
• W3039593619 hasConceptScore W3039593619C42219234 @default.
• W3039593619 hasConceptScore W3039593619C46821324 @default.
• W3039593619 hasConceptScore W3039593619C50952357 @default.
• W3039593619 hasConceptScore W3039593619C537181965 @default.
• W3039593619 hasConceptScore W3039593619C71924100 @default.
• W3039593619 hasConceptScore W3039593619C98274493 @default.
• W3039593619 hasLocation W30395936191 @default.
• W3039593619 hasLocation W30395936192 @default.
• W3039593619 hasOpenAccess W3039593619 @default.
• W3039593619 hasPrimaryLocation W30395936191 @default.
• W3039593619 hasRelatedWork W1971467119 @default.
• W3039593619 hasRelatedWork W1991845725 @default.
• W3039593619 hasRelatedWork W1998924331 @default.
• W3039593619 hasRelatedWork W2019593726 @default.
• W3039593619 hasRelatedWork W2073452482 @default.
• W3039593619 hasRelatedWork W2075377923 @default.
• W3039593619 hasRelatedWork W2134037778 @default.
• W3039593619 hasRelatedWork W2556860094 @default.
• W3039593619 hasRelatedWork W2825978630 @default.
• W3039593619 hasRelatedWork W4292246210 @default.
• W3039593619 isParatext "false" @default.
• W3039593619 isRetracted "false" @default.
• W3039593619 magId "3039593619" @default.
• W3039593619 workType "article" @default.